Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis Pharma GmbH
Woman and Man Max 99 years
Novartis Pharma GmbH
Update Il y a 4 ans
A multi-center, prospective, open-label, 8-weeks study to investigate the efficacy, safety and pharmacokinetics of certoparin (3000 IU anti-Xa bolus, with the option to titrate dose) in the prophylaxis of clotting in the extracorporeal circuit in patients undergoing chronic hemodialysis
The primary objective is to investigate the efficacy of certoparin to prevent clotting in the extracorporeal circulation during hemodialysis at week 8. The primary endpoint is the percentage of unsati...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
2
3
4
5
6
7
8
9
10
11